↓ Skip to main content

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy

Overview of attention for article published in Frontiers in immunology, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
Published in
Frontiers in immunology, May 2022
DOI 10.3389/fimmu.2022.899710
Pubmed ID
Authors

Chubei Teng, Yongwei Zhu, Yueshuo Li, Luohuan Dai, Zhouyang Pan, Siyi Wanggou, Xuejun Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 13%
Researcher 2 13%
Student > Ph. D. Student 1 6%
Student > Bachelor 1 6%
Unknown 10 63%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 13%
Engineering 2 13%
Medicine and Dentistry 1 6%
Immunology and Microbiology 1 6%
Unknown 10 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2022.
All research outputs
#8,271,973
of 26,178,577 outputs
Outputs from Frontiers in immunology
#10,008
of 32,859 outputs
Outputs of similar age
#152,977
of 448,426 outputs
Outputs of similar age from Frontiers in immunology
#509
of 1,780 outputs
Altmetric has tracked 26,178,577 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 32,859 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,426 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 1,780 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.